|View printer-friendly version|
|June 25, 2006 1:51 p.m.|
|Teva Receives First U.S. Approval of Generic Zocor® Tablets; Product to be Shipped Immediately|
Jerusalem, Israel, June 25, 2006 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Merck's Zocor® (Simvastatin) Tablets, 5 mg, 10 mg, 20 mg, and 40 mg. Shipment of these products has commenced.